Dr. Sadollah Abedini, MD, PhD - Vestfold Hospital Trust  - Consultant nephrologist

Dr. Sadollah Abedini

MD, PhD

Vestfold Hospital Trust

Consultant nephrologist

Toensberg, Vestfold | Norway

Additional Specialties: Internal medicine, nephrology

Dr. Sadollah Abedini, MD, PhD - Vestfold Hospital Trust  - Consultant nephrologist

Dr. Sadollah Abedini

MD, PhD

Introduction

Primary Affiliation: Vestfold Hospital Trust - Toensberg, Vestfold , Norway

Additional Specialties:

Research Interests:


View Dr. Sadollah Abedini’s Resume / CV

Education

Jan 2007
Specialist in nephrology, Oslo Norway
Nephrologist
Jan 2004
Specialist in Internal medicine, Oslo Norway
Internal medicine
Jan 2004
Specialist in Internal medicine, Oslo Norway
Internal medicine
Feb 1995
University of Copenhagen, Denmark
MD
Copenhagen, Denmark
Feb 1995
University of Copenhagen, Denmark
MD
undefined
undefined
undefined
undefined
undefined
undefined
undefined
undefined
undefined

Experience

Jan 2019

see the CV attached

Publications

17Publications

230Reads

702Profile Views

168PubMed Central Citations

Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.

Transplantation 2015 Jul;99(7):1470-6

1 Division of Nephrology, Department of Medicine, University Hospital Würzburg, Würzburg, Germany. 2 Comprehensive Heart Failure Centre, University Hospital of Würzburg, Würzburg, Germany. 3 Department of Organ Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway. 4 Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. 5 Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care, Research, VU University Medical Centre, Amsterdam, the Netherlands. 6 Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical, University of Graz, Graz, Austria. 7 Department of Cardiology, Medical University of Graz, Graz, Austria. 8 Specialist Clinic for Rehabilitation Bad Aussee, Bad Aussee, Austria. 9 Division of Nephrology, Department of Medicine, Sykehuset i Vestfold, Tønsberg, Norway. 10 Division of Nephrology, Department of Internal Medicine, Uppsala University Hospital, Uppsala, Sweden. 11 Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. 12 Department of Medicine V (Nephrology, Hypertensiology, Endocrinology, Rheumatologie) Mannheim Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. 13 Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. 14 Synlab Academy, Synlab Services, Mannheim, Germany.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/transplantjournal/2015/07000/Ho
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/TP.0000000000000568DOI Listing
July 2015
8 Reads
1 Citation
3.830 Impact Factor

Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.

Transplantation 2015 Feb;99(2):351-9

1 Division of Nephrology, Department of Organ Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway. 2 Division of Nephrology, Department of Medicine, Oslo University Hospital Ullevål, Oslo, Norway. 3 Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria. 4 Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, the Netherlands. 5 Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. 6 Synlab Center of Laboratory Diagnostics, Heidelberg, Germany. 7 Medical Faculty Mannheim, Mannheim Institute of Public Health, Social and Preventive Medicine, University of Heidelberg, Mannheim, Germany. 8 Division of Nephrology, Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway. 9 Department of Preventive Medicine and Unit of Biostatistics and Epidemiology, Oslo University Hospital Ullevål, Oslo, Norway. 10 Division of Nephrology, Department of Internal Medicine, Uppsala University Hospital, Uppsala, Sweden. 11 British Heart Foundation, Glasgow Cardiovascular Research Centre, Glasgow, G12 8TA, Scotland, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000583DOI Listing
February 2015
12 Reads
12 Citations
3.830 Impact Factor

Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients.

Transplantation 2014 Dec;98(11):1219-25

1 Division of Nephrology, Department of Organ Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway. 2 Division of Nephrology, Department of Medicine, Oslo University Hospital Ullevål, Oslo, Norway. 3 Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria. 4 Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, the Netherlands. 5 Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. 6 Synlab Center of Laboratory Diagnostics, Heidelberg, Germany. 7 Medical Faculty Mannheim, Mannheim Institute of Public Health, Social and Preventive Medicine, University of Heidelberg, Mannheim, Germany. 8 Department of Medicine, Division of Nephrology, Vestfold Hospital, Tønsberg, Norway. 9 Department of Preventive Medicine and Unit of Biostatistics and Epidemiology, Oslo University Hospital Ullevål, Oslo, Norway. 10 Division of Nephrology, Department of Internal Medicine, Uppsala University Hospital, Uppsala, Sweden. 11 British Heart Foundation, Glasgow Cardiovascular Research Centre, Glasgow, Scotland, United Kingdom. 12 Address correspondence to: Hege Pihlstrøm, M.D., Department of Organ Transplantation, Division of Nephrology, Oslo University Hospital, Rikshospitalet, P.B. 4950 Nydalen, 0424 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240460PMC
December 2014
10 Reads
5 Citations
3.830 Impact Factor

Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study.

Clin Transplant 2013 Nov-Dec;27(6):E636-43. Epub 2013 Sep 2.

Department of Nephrology, Aalborg University Hospital, Aalborg, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ctr.12220DOI Listing
August 2014
3 Reads
1 Citation
1.490 Impact Factor

Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients.

Clin Transplant 2014 Jan 24;28(1):111-9. Epub 2013 Dec 24.

Department of Organ Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ctr.12285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204514PMC
January 2014
10 Reads
1 Citation
1.490 Impact Factor

Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trial.

J Nephrol 2012 Mar-Apr;25(2):245-54

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/JN.2011.8450DOI Listing
August 2012
8 Reads
2.000 Impact Factor

Inflammation-associated graft loss in renal transplant recipients.

Nephrol Dial Transplant 2011 Nov 21;26(11):3756-61. Epub 2011 Apr 21.

Department of Nephrology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfr163DOI Listing
November 2011
10 Reads
9 Citations
3.580 Impact Factor

Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment.

Clin Transplant 2009 Nov-Dec;23(6):914-20. Epub 2009 Jul 5.

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-0012.2009.01025.xDOI Listing
September 2010
14 Reads
1 Citation
1.490 Impact Factor

Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients.

Kidney Int 2010 Jan;77(1):44-50

Department of Medicine, Renal Section, Toensberg County Hospital, Toensberg, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2009.382DOI Listing
January 2010
11 Reads
18 Citations
8.563 Impact Factor

Inflammation in renal transplantation.

Clin J Am Soc Nephrol 2009 Jul 18;4(7):1246-54. Epub 2009 Jun 18.

Renal Section, Department of Medicine, Toensberg County Hospital, Toensberg, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.00930209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709521PMC
July 2009
7 Reads
15 Citations
4.613 Impact Factor

Cerebrovascular events in renal transplant recipients.

Transplantation 2009 Jan;87(1):112-7

Department of Medicine, Renal Section, National Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0b013e31818bfce8DOI Listing
January 2009
110 Reads
6 Citations
3.830 Impact Factor

No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.

Clin Transplant 2006 Nov-Dec;20(6):732-9

Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-0012.2006.00555.xDOI Listing
February 2007
4 Reads
3 Citations
1.490 Impact Factor

Effects of pharmacological modulation of the ATP-sensitive potassium channels on the development of warm-up angina pectoris.

Cardiology 2006 15;105(1):17-21. Epub 2005 Sep 15.

Department of Cardiology, Bispebjerg Hospital, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000088266DOI Listing
March 2006
4 Reads
2.044 Impact Factor

Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease.

Eur Heart J 2004 Mar;25(5):363-70

Department of Cardiology, Copenhagen University Hospital of Bispebjerg, Bispebjerg Bakke 23, Copenhagen NV 2400, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ehj.2003.12.003DOI Listing
March 2004
3 Reads
73 Citations
15.203 Impact Factor

[Acute groin pain and femoral nerve deficit in a warfarin treated patient].

Tidsskr Nor Laegeforen 2002 Oct;122(24):2360-1

Medisinsk avdeling, Sykehuset i Vestfold Tønsberg, 3103 Tønsberg.

View Article

Download full-text PDF

Source
October 2002
5 Reads